Skip to main content
SpringerLink
Log in

Platelet research in psychiatry

  • Multi-author Review
  • The Platelet in Pathophysiological Research
  • Published:
Experientia Aims and scope Submit manuscript

Summary

The platelet is one of the most researched biological markers in psychiatry. Characteristics of MAO activity, 5-HT uptake, imipramine andα 2-adrenergic receptor binding, for example, are similar in platelet and CNS. Methodological factors are not negligible, and range from diagnostic specificity and drug effects to the normal physiological variability of age and hormone-related changes, circadian and seasonal rhythms. As yet, there are no clear state or trait platelet markers in affective disorders and schizophrenia that can be unequivocally used to detect vulnerability to the illness, predict therapeutic response, define clinical diagnostic entities or follow the course of the illness. However, platelet markers are increasingly being used in careful studies to monitor psychopharmacological effects (an in vivo assay of all active metabolites), different ligands can be specific markers for certain aspects of a psychiatric illness (e.g.α 2-adrenergic receptors and weight loss), and this homogeneous preparation of human cells is an increasingly important tool in studying mechanisms in pathophysiology. More longitudinal studies are required to establish functional relationships between platelet variables and psychopathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ackenheil, M., Bondy, B., and Fröhler, M., Interactions between catecholamines and their receptors in blood. Clin. Neuropharmac.9 (1986) 119–121.

    Google Scholar 

  2. Ahtee, L., Briley, M., Raisman, R., Lebree, D., and Langer, S. Z., Reduced uptake of serotonin but unchanged3H-imipramine binding in the platelets from cirrhotic patients. Life Sci.29 (1981) 2323–2329.

    Article  CAS  PubMed  Google Scholar 

  3. Albus, M., Bondy, B., and Ackenheil, M., Adrenergic receptors on blood cells: Relation to the pathophysiology of anxiety. Clin. Neuropharmac.9 (1986) 359–361.

    Google Scholar 

  4. American Psychiatric Association, Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC 1980.

  5. Arora, R. C., and Meltzer, H. Y., Serotonin uptake by blood platelets of schizophrenic patients. Psychiat. Res.6 (1982) 327–333.

    Article  CAS  Google Scholar 

  6. Arora, R. C., Kregel, L., and Meltzer, H. Y., Circadian rhythm of serotonin uptake in the blood platelets of normal controls. Biol. Psychiat.19 (1984) 1579–1584.

    CAS  PubMed  Google Scholar 

  7. Arora, R. C., Kregel, L., and Meltzer, H. Y., Seasonal variation of serotonin uptake in normal controls and depressed patients. Biol. Psychiat.19 (1984) 795–804.

    CAS  PubMed  Google Scholar 

  8. Arora, R. C., Wunnicke, V., and Meltzer, H. Y., Effect of protein concentration on kinetic constants of3H-imipramine binding in blood platelets. Biol. Psychiat.20 (1985) 94–119.

    Article  Google Scholar 

  9. Asarch, K. B., Shrih, J. C., and Kulcrar, A., Decreased3H-imipramine binding in depressed males and females. Commun. Psychopharmac.4 (1980) 425–432.

    CAS  Google Scholar 

  10. Asberg, M., Biochemical aspects of suicide. Clin. Neuropharm.9 (1986) 374–376.

    Google Scholar 

  11. Barkai, A. I., Kowalik, S., and Baron, M., Effect of membrane protein concentration on binding of3H-imipramine in human platelets. Biol. Psychiat.20 (1985) 199–228.

    Article  Google Scholar 

  12. Baron, M., Barkai, A., and Gruen, R., Platelet [3H]-imipramine binding in affective disorders: trait versus state characteristics. Am. J. Psychiat.143 (1986) 711.

    Article  CAS  PubMed  Google Scholar 

  13. Berrettini, W. H., Nurnberger, J. I., Worthington, E. K., Simmons-Alling, S., and Gershon, E. S., Platelet vasopressin receptors in bipolar affective illness. Psychiat. Res.7 (1982) 83–86.

    Article  CAS  Google Scholar 

  14. Braddock, L. E., Cowen, P. J., Elliot, J. M., Fraser, S., and Stump, K., Changes in platelet3H-imipramine and3H-yohimbine binding in normal subjects taking amitriptyline. Neuropharm.23 (1984) 285–286.

    Article  CAS  Google Scholar 

  15. Briley, M., Imipramine binding: its relationship with serotonin uptake and depression, in: Neuropharmacology of Serotonin, pp. 50–78. Ed. A. R. Green, Oxford University Press, Oxford 1985.

    Google Scholar 

  16. Briley, M. S., Langer, S. Z., Raisman, R., Sechter, D., and Zarifian, E., Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science209 (1980) 303–305.

    Article  CAS  PubMed  Google Scholar 

  17. Brodde, O. E., Anlauf, M., Graben, N., and Bock, K. D., Age-dependant decrease ofα2-adrenergic receptor number in human platelets. Eur. J. Pharmac.81 (1982) 345–347.

    Article  CAS  Google Scholar 

  18. Buchsbaum, M. S., Coursey, R. D., and Murphy, D. L., The biochemical high-risk paradigm: Behavioral and familial correlates of low platelet monoamine oxidase activity. Science194 (1976) 339–341.

    Article  CAS  PubMed  Google Scholar 

  19. Buckley, C., Curtin, D., Walsh, T., and O’Malley, K., Ageing and plateletα2-adrenoceptors. Br. J. clin. Pharmac.21 (1986) 721–722.

    Article  CAS  Google Scholar 

  20. Cameron, O. G., Smith, C. B., Hollingsworth, P. J., Nesse, R. M., and Curtis, G. C., Plateletα2-adrenoceptors receptor binding and plasma catecholamines. Archs gen. Psychiat.14 (1984) 1144–1148.

    Article  Google Scholar 

  21. Campell, I. C., Blood platelets and psychiatry. Br. J. Psychiat.138 (1981) 78–80.

    Article  Google Scholar 

  22. Carstens, M. E., Engelbrecht, A. H., Russell, V. A., Aalbers, C., Gagiano, C. A., Chalton, D. O., and Taljaard, J. J. F., Imipramine binding sites on platelets of patients with major depressive disorder. Psychiat. Res.18 (1986) 333–342.

    Article  CAS  Google Scholar 

  23. Carstens, M. E., Engelbrecht, A. H., Russell, V. A., Aalbers, C., Gagiano, C. A., Chalton, D. O., and Taljaard, J. J. F., Alpha-2-adrenoceptor levels on platelets of patients with major depressive disorders. Psychiat. Res.18 (1986) 321–331.

    Article  CAS  Google Scholar 

  24. Cloninger, C. R., von Knorring, L., and Oreland, L., Pentametric distribution of platelet monoamine oxidase activity. Psychiat. Res.15 (1985) 133–143.

    Article  CAS  Google Scholar 

  25. Coppen, A., Swade, C., and Wood, K., Platelet 5-hydroxytryptamine accumulation in depressive illness. Clinica chim. Acta87 (1978) 165–168.

    Article  CAS  Google Scholar 

  26. Corash, L., Platelet heterogeneity: relevance to the use of platelets to study psychiatric disorders. Schizophrenia Bull.6 (1980) 255–258.

    Article  Google Scholar 

  27. Daiguji, M., Meltzer, H. Y., Tong, C., U’Prichard, D. C., Young, M., and Kravitz, H., Alpha-2-adrenergic receptors in platelet membranes of depressed patients: No change in number or3H-yohimbine affinity. Life Sci.29 (1981) 2059–2064.

    Article  CAS  PubMed  Google Scholar 

  28. Doyle, M. C., George, A. J., Ravindran, A. V., and Philpott, R., Plateletα2-adrenoceptors binding in elderly depressed patients. Am. J. Psychiat.142 (1985) 1489–1490.

    Article  CAS  PubMed  Google Scholar 

  29. Ebstein, R. P., Lerer, B., Bennett, E. R., Ben Dayek, D., Newman, M. E., Shapira, B., and Kindler, S., Second messenger function in lymphocytes and platelets: A comparison of peripheral and central mechanisms. Clin. Neuropharmac.4 (1986) 350–352.

    Google Scholar 

  30. Egrise, D., Desmedt, D., Schoutens, A., and Mendlewicz, J., Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man. Neuropsychobiology10 (1983) 101–102.

    Article  CAS  PubMed  Google Scholar 

  31. Egrise, D., Rubinstein, M., Schoutens, A., Cantraine, F., and Mendlewicz, J., Seasonal variation of platelet serotonin uptake and3H-imipramine binding in normal and depressed subjects. Biol. Psychiat.21 (1986) 283–292.

    Article  CAS  PubMed  Google Scholar 

  32. Ehsanullah, R. S. B., Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects-influence of clomipramine, desmethylclomipramine and maprotiline. Postgrad. med. J., Suppl. 1 (1980) 31–35.

    Google Scholar 

  33. Elliott, J. M., Platelet receptor binding studies in affective disorders. J. affect. Dis.6 (1984) 219–239.

    Article  CAS  PubMed  Google Scholar 

  34. Friedl, W., Propping, P., and Weck, B.,3H-Imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding. Psychopharmacology80 (1983) 96–99.

    Article  CAS  PubMed  Google Scholar 

  35. Fröhler, M., Saito, Y., Ackenheil, M., Bak, R., Bondy, B., Feistenauer, E., Hofschuster, E., Vakis, A., and Welter, D., Catecholaminergic binding sites on blood cells of healthy volunteers with special respect to circadian rhythms. Pharmacopsychiatry1 (1985) 147–148.

    Article  Google Scholar 

  36. Galzin, A. M., Loo, H., Sechter, D., and Langer, S. Z., Lack of seasonal variation in platelet [3H]-imipramine binding in humans. Biol. Psychiat.21 (1986) 876–882.

    Article  CAS  PubMed  Google Scholar 

  37. Garcia-Sevilla, J. A., Zis, A. P., Hollingsworth, P. J., Greden, J. F., and Smith, C. B., Plateletα2-adrenergic receptors in major depressive disorder. Archs. gen. Psychiat.38 (1981) 1327–1333.

    CAS  Google Scholar 

  38. Garcia-Sevilla, J. A., Zis, A. P., Zelnik, T. C., and Smith, C. B., Tricyclic antidepressant drug treatment decreases alpha-2-adrenoceptors on human platelet membranes. Eur. J. Pharmac.69 (1981) 121–122.

    Article  CAS  Google Scholar 

  39. Gay, C., Langer, S. Z., Loo, H., Raisman, R., Sechter, D., and Zarifian, E.,3H-Imipramine binding in platelets-a state-dependent biological marker in depression? Br. J. Pharmac. Chemother.78 (1983) 57P.

    Google Scholar 

  40. Gentsch, C., Lichtsteiner, M., Gastpar, M., Gastpar, G., and Feer, H.,3H-Imipramine binding sites in platelets of hospitalized psychiatric patients. Psychiat. Res.14 (1984) 177–187.

    Article  Google Scholar 

  41. Hallstrom, C. O. S., Pare, C. M. B., Rees, W. L., Trenchard, A., and Turner, P., Platelet uptake of 5-hydroxytryptamine and dopamine in depression. Postgrad. med. J.52 (1976) 40–44.

    CAS  PubMed  Google Scholar 

  42. Hamilton, C. A., Jones, C. R., Mishra, N., Barr, S., and Reid, J. L., A comparison ofα2-adrenoceptors regulation in brain and platelets. Brain Res.347 (1985) 350–353.

    Article  CAS  PubMed  Google Scholar 

  43. Haug, H. J., Fähndrich, E., Strauss, S., and Rommelspacher, H., Sleep deprivation and imipramine binding sites in depressed patients and healthy subjects. Psychiat. Res. (1987) in press.

  44. Heufelder, A., Warnhoff, M., and Pirke, K. M., Plateletα2-adrenoceptors and adenylate cyclase in patients with anorexia nervosa and bulimia. J. clin. Endocr. Metab.61 (1985) 1053–1060.

    Article  CAS  PubMed  Google Scholar 

  45. Hrdina, P. D., Lapierre, Y. D., Horn, E. R., and Bakish, D., Platelet3H-imipramine binding: A possible predictor of response to antidepressant treatment. Prog. Neuropsychopharmac. Biol. Psych.9 (1985) 619–622.

    Article  CAS  Google Scholar 

  46. Humphries, L. L., Shirley, P., Allen, M., Codd, E. E., and Walker, R. F., Daily patterns of serotonin uptake in platelets from psychiatric patients and control volunteers. Biol. Psychiat.20 (1985) 1073–1081.

    Article  CAS  PubMed  Google Scholar 

  47. Jackman, H. Y., and Meltzer, H. Y., Factors affecting determination of platelet monoamine oxidase activity. Schizophrenia Bull.6 (1980) 259–262.

    Article  CAS  Google Scholar 

  48. Jones, S. B., Bylund, D. B., Rieser, C. A., Shekim, W. O., and Byer, J. A.,α2-Adrenergic receptor binding in human platelets: Alterations during the menstrual cycle. Clin. Pharmac. Ther.34 (1983) 90–96.

    Article  CAS  Google Scholar 

  49. Kafka, M. S. and Paul, S. M., Plateletα2-adrenergic receptors in depression. Archs gen. Psychiat.43 (1986) 91–95.

    Article  CAS  Google Scholar 

  50. Kafka, M. S., Siever, L. J., Nurnberger, J. I., Uhde, T. W., Targum, S., Cooper, D. M. J., Kammen, D. P., and Tokola, N. S., Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia. Psychopharmac. Bull.21 (1985) 599–602.

    CAS  Google Scholar 

  51. Kaye, W. H., Gwirtsman, H. E., Lake, R., Siever, L. J., Jimerson, D. C., Ebert, M. H., and Murphy, D. L., Disturbances of norepinephrine metabolism andα2-adrenergic receptor activity in anorexia nervosa: Relationship to nutritional state. Psychopharmac. Bull.21 (1985) 419–423.

    CAS  Google Scholar 

  52. von Knorring, L., Oreland, L., and Winblad, B., Personality traits related to monoamine oxidase activity in platelets. Psychiat. Res.12 (1984) 11–26.

    Article  Google Scholar 

  53. Ko, G. N., Unnerstall, J. R., Kuhar, M. J., Wyatt, R. J., and Kleinman, J. E., Alpha-2-adrenergic agonist binding in schizophrenic brains. Psychopharmac. Bull.22 (1986) 1011–1016.

    CAS  Google Scholar 

  54. Langer, S. Z., Zarifian, E., Briley, M., Raisman, R., and Sechter, D., High-affinity binding of3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci.29 (1981) 211–220.

    Article  CAS  PubMed  Google Scholar 

  55. Langer, S. Z., Zarifian, E., Briley, M., Raisman, R., and Sechter, D., High affinity3H-imipramine binding: A new biological marker in depression. Pharmacopsychiatry15 (1982) 4–10.

    Article  CAS  Google Scholar 

  56. Lewis, D. A., and McChesney, C., Tritiated imipramine binding to platelets in manic subjects. J. affect. Dis.9 (1985) 207–211.

    Article  CAS  PubMed  Google Scholar 

  57. Lewis, D. A., Noyes, R., Coryell, W., and Clancy, J., Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiat. Res.16 (1985) 1–9.

    Article  CAS  Google Scholar 

  58. Lingjaerde, O., Blood platelets as a model system for studying the biochemistry of depression, in: Frontiers in Biochemical and Pharmacological Research in Depression, pp. 99–111. Ed. F. Sjöquist. Raven Press, New York 1984.

    Google Scholar 

  59. Lingjaerde, O., Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics. Biol. Psychiat.18 (1983) 1345–1356.

    CAS  PubMed  Google Scholar 

  60. Luck, P., Mikhailidis, D. P., Dashwood, M. R., Barradas, M. A., Sever, P. S., Dandona, P., and Wakeling, A., Platelet hyperaggregability and increased α-adrenoceptor density in anorexic nervosa. J. clin. Endocr. Metab.57 (1983) 911–914.

    Article  CAS  PubMed  Google Scholar 

  61. Malmgren, R., Asberg, M., Olsson, P., Tornling, G., and Unge, G., Defective serotonin transport mechanism in platelets from endogenously depressed patients. Life Sci.29 (1981) 2649–2658.

    Article  CAS  PubMed  Google Scholar 

  62. Mellerup, E. T., Plenge, P., and Rosenberg, R.,3H-Imipramine binding sites in platelets from psychiatric patients. Psychiat. Res.7 (1982) 221–227.

    Article  CAS  Google Scholar 

  63. Meltzer, H. Y., Arora, R. C., and Goodnick, P., Effect of lithium carbonate on serotonin uptake in blood platelets of patients with affective disorders. J. affect. Dis.5 (1983) 215–221.

    Article  CAS  PubMed  Google Scholar 

  64. Meltzer, H. Y., Arora, R. C., Tricou, B. J., and Fang, V. S., Serotonin uptake in blood platelets and the dexamethasone suppression test in depressed patients. Psychiat. Res.8 (1983) 41–47.

    Article  CAS  Google Scholar 

  65. Meyerson, L. R., Wennogle, L. P., Abel, M. S., Coupet, J., Lippa, A. S., Rauh, C. E., and Beer, B., Human brain receptor alterations in suicide victims. Pharmac. biochem. Behav.17 (1982) 159.

    Article  CAS  Google Scholar 

  66. Modai, I., Zemishlany, Z., and Jerushalmy, Z., 5-Hydroxytryptamine uptake by blood platelets of unipolar and bipolar depressed patients. Neuropsychobiology12 (1984) 93–95.

    Article  CAS  PubMed  Google Scholar 

  67. Modai, I., Malmgren, R., Asberg, M., and Beving, H., Circadian rhythm of serotonin transport in human platelets. Psychopharmacology88 (1986) 493–495.

    Article  CAS  PubMed  Google Scholar 

  68. Modai, I., Rotman, A., Munitz, H., Tjano, S., and Wijsenbeek, H., Serotonin uptake by blood platelets of acute schizophrenic patients. Psychopharmacology64 (1979) 193–195.

    Article  CAS  PubMed  Google Scholar 

  69. Mück-Seler, D., Deanovic, Z., Jamnicky, B., Jakupcevic, M., and Mihovilovic, M., Maprotiline in the treatment of endogenous depression: Comparison of therapeutic effect with serotonin level in blood platelets. Psychopharmacology79 (1983) 262–265.

    Article  PubMed  Google Scholar 

  70. Murphy, D. L., Lipper, S., Pickar, D., Jimerson, D., Cohen, R. M., Garrick, N. A., Alterman, I. S., and Campbell, I. C., Selective inhibition of monoamine oxidase type A: Clinical antidepressant effect and metabolic changes in man, in: Monoamine Oxidase Inhibitors. The State of the Art, pp. 189–205. Eds M. B. Youdim and E. S. Paykel. John Wiley, Chichester 1981.

    Google Scholar 

  71. Murphy, D. L., Wright, C., Buchsbaum, M. S., Nichols, A., Costa, J. L., and Wyatt, R. J., Platelet and plasma amine oxidase activity in 680 normals: Sex and age diferences and stability over time. Biochem. Med.16 (1976) 254–265.

    Article  CAS  Google Scholar 

  72. Muscettola, G., DiLauro, A., and Giannini, C. P., Platelet3H-imipramine binding in bipolar patients. Psychiat. Res.18 (1986) 343–353.

    Article  CAS  Google Scholar 

  73. Muscettola, G., DiLauro, A., and Giannini, C. P., Blood cells as biological trait markers in affective disorders. J. psychiat. Res.18 (1984) 447–456.

    Article  CAS  PubMed  Google Scholar 

  74. Nankai, M., Yoshimoto, S., Narita, K., and Takahashi, R., Platelet [3H] imipramine binding in depressed patients and its circadian variations in healthy controls. J. affect. Dis.11 (1986) 207–212.

    Article  CAS  PubMed  Google Scholar 

  75. Nies, A., Robinson, D. S., Lamborn, K. R., Lampert, R. T., and Burlington, V. T., Genetic control of platelet and plasma monoamine oxidase activity. Archs gen. Psychiat.28 (1973) 834–838.

    Article  CAS  Google Scholar 

  76. Norman, T. R., Judd, F. K., Gregory, M., James, R. H., Kimber, N. M., McIntyre, D. M., and Burrows, G. D., Platelet serotonin uptake in panic disorder. J. affect. Dis.11 (1986) 69–72.

    Article  CAS  PubMed  Google Scholar 

  77. Oreland, L., Wiberg, A., and Fowler, C. J., Monoamine oxidase activity in platelets as related to monoamine oxidase activity and monoaminergic function in the brain. Adv. Neuropsychopharmac.9 (1981) 195–201.

    Google Scholar 

  78. Paul, S. M., Rehavi, M., Skolnick, P., Ballenger, J. C., and Goodwin, F. K., Depressed patients have decreased binding of3H-imipramine to the platelet serotonin ‘transporter’. Archs gen. Psychiat.38 (1981) 1315–1317.

    Article  CAS  Google Scholar 

  79. Pecknold, J. C., and Suranyi-Cadotte, B. E., Panic disorder and depression: 5 HT and imipramine binding studies. Clin. Neuropharmac.9 (1986) 46–48.

    Google Scholar 

  80. Perry, E. K., Marshall, E. F., Blessed, G., Tomlinson, B. E., and Perry, R. H., Decreased imipramine binding in the brains of patients with depressive illness. Br. J. Psychiat.142 (1983) 188–192.

    Article  CAS  Google Scholar 

  81. Piletz, J. E., and Halaris, A., Yohimbine and clonidine recognize different states of adrenergic receptors on human platelets: Reconsideration of studies on platelet alpha-2-receptors in depressive illness. Psychopharmac. Bull.21 (1985) 573–578.

    CAS  Google Scholar 

  82. Pletscher, A., Affolter, H., Cesura, M., Erne, E., and Müller, K., Blood platelets as models for neurons: Similarities of the 5-hydroxytryptamine systems, in: Progress in Tryptophan and Serotonin Research, pp. 231–239. Eds H. G. Schlossberger, W. Kochen, B. Linzen, and H. Steinhart. de Gruyter W. & Co., Berlin 1984.

    Google Scholar 

  83. Poirier, M. F., Benkelfat, Ch., Galzin, A. M., and Langer, S. Z., Platelet3H-imipramine binding and steroid hormone serum concentrations during the menstrual cycle. Psychopharmacology88 (1986) 86–89.

    Article  CAS  PubMed  Google Scholar 

  84. Raisman, R., Sechter, D., Briley, M. S., Zarifian, E., and Langer, S. Z., High affinity3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology75 (1982) 268–371.

    Google Scholar 

  85. Rausch, J. L., Shah, N. S., Burch, E. A., Donald, A. G., and Munson, E. V., A study of circadian variation of platelet serotonin uptake and serum cortisol in patients with major depression, in: Psychoneuroendocrinology in Psychiatry and Neurology, pp. 473–485. Ed. N. S. Shah. Plenum Press, New York 1984.

    Google Scholar 

  86. Rausch, J. L., Shah, N. S., Burch, E. A., and Donald, A. G., Platelet serotonin uptake in depressed patients: Circadian effect. Biol. Psychiat.17 (1982) 121–123.

    CAS  PubMed  Google Scholar 

  87. Rehavi, M., Paul, S., Skolnick, P., and Goodwin, F. K., Demonstration of specific high affinity binding sites for3H-imipramine in human brain. Life Sci.16 (1980) 2273–2279.

    Article  Google Scholar 

  88. Rice, J., McGuffin, P., Goldin, L. R., Shaskan, E. G., and Gershon, E. S., Platelet monoamine oxidase (MAO) activity: Evidence for a single major locus. Am. J. hum. Genet.36 (1984) 36.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Rieder, R., and Gershon, E. S., Genetic strategies in biological psychiatry. Archs gen. Psychiat.35 (1978) 866–873.

    Article  CAS  Google Scholar 

  90. Robinson, D. S., and Nies, A., Demographic and other variables affecting monoamine oxidase activity. Schizophrenia Bull.2 (1980) 298–307.

    Article  Google Scholar 

  91. Rose, S. P. R., and Murphy, S., Psychotherapy and imipramine binding to blood platelets. Abstract IBRO Conference, Budapest 1987.

  92. Rosen, J., Silk, K. R., Rice, H. E., and Smith, C. B., Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: A preliminary study. Biol. Psychiat.20 (1985) 539–545.

    Article  CAS  PubMed  Google Scholar 

  93. Rotman, A., Blood platelets in psychopharmacological research. Progr. Neuropsychopharmac.6 (1982) 57–61.

    Article  CAS  Google Scholar 

  94. Rotman, A., Zemishlany, Z., Munitz, H., and Wijsenbeek, H., The active uptake of serotonin by platelets of schizophrenic patients and their families: possibility of a genetic marker. Psychopharmacology77 (1982) 171–174.

    Article  CAS  PubMed  Google Scholar 

  95. Sarai, K., and Kayano, M., The level and diurnal rhythm of serotonin in manic-depressive patients. Folia psychiat. neurol. jap.22 (1968) 271–280.

    CAS  PubMed  Google Scholar 

  96. Schneider, L. S., Munjack, D., Severson, J. A., and Palmer, R., Platelet [3H] imipramine binding in generalized anxiety disorders, panic disorder, and agoraphobia with panic attacks. Biol. Psychiat.22 (1987) 59–66.

    Article  CAS  PubMed  Google Scholar 

  97. Scott, M., Reading, H. W., and Loudon, J. B., Studies on human blood platelets in affective disorder. Psychopharmacology60 (1979) 131–135.

    Article  CAS  PubMed  Google Scholar 

  98. Siever, L. J., Kafka, M. S., Targum, S., and Lake, C. R., Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiat. Res.11 (1984) 287–302.

    Article  CAS  Google Scholar 

  99. Siever, L. J., Kafka, M. S., Insel, T. R., Lake, C. R., and Murphy, D. L., Effect of long-term clorgyline administration on human platelet alpha-adrenergic receptor binding and platelet cyclic AMP responses. Psychiat. Res.9 (1983) 37–44.

    Article  CAS  Google Scholar 

  100. Smith, C. B., Hollingsworth, P. J., Garcia-Sevilla, J. A., and Zis, A. P., Platelet alpha-2-adrenoreceptors are decreased in number after antidepressant therapy. Prog. Neuropsychopharmac.7 (1983) 241–247.

    Article  CAS  Google Scholar 

  101. Stahl, S. M., Platelets as pharmacologic models for the receptors and biochemistry of monoaminergic neurons, in: The Platelet: Physiology and Pharmacology, pp. 307–340. Academic Press, New York 1985.

    Chapter  Google Scholar 

  102. Stahl, S. M., Peripheral models for the study of neurotransmitter receptors in man. Psychopharmac. Bull.21 (1985) 663–671.

    CAS  Google Scholar 

  103. Stahl, S. M., Lemoine, P. M., Ciaranello, R. D., and Berger, P. A., Platelet alpha-2-adrenergic receptor sensitivity in major depressive disorder. Psychiat. Res.10 (1983) 157–164.

    Article  CAS  Google Scholar 

  104. Stahl, S. M., Woo, D. J., Mefford, I. N., Berger, P. A., and Ciaranello, R. D., Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am. J. Psychiat.140 (1983) 26–30.

    Article  CAS  PubMed  Google Scholar 

  105. Stanley, M., Virgilio, J., and Gershon, S., Tritiated imipramine bindings sites are decreased in the frontal cortex of suicides. Science216 (1982) 1337–1339.

    Article  CAS  PubMed  Google Scholar 

  106. Sundaresan, P. R., Madan, M. K., Kelvie, S. L., and Weintraub, M., Platelet alpha-2-adrenoceptors and the menstrual cycle. Clin. Pharmac. Ther.37 (1985) 337–342.

    Article  CAS  Google Scholar 

  107. Sundaresan, P. R., Weintraub, M., Hershey, L. A., Kroening, B. H., Hasday, J. D., and Banerjee, S. P., Platelet alpha-2-adrenergic receptors in obesity: Alteration with weight loss. Clin. Pharmac. Ther.33 (1983) 776–785.

    Article  CAS  Google Scholar 

  108. Suranyi-Cadotte, B., Wood, P. L., Schwartz, G., and Nair, N. P. V., Altered platelet3H-imipramine binding in schizo-affective and depressive disorders. Biol. Psychiat.18 (1983) 923–927.

    CAS  PubMed  Google Scholar 

  109. Suranyi-Cadotte, B. E., Gauthier, S., Lafaille, F., DeFlores, S., Dam, T. V., Nair, N. P. V., and Quirion, R., Platelet3H-imipramine binding distinguishes depression from Alzheimer dementia. Life Sci.37 (1985) 2305–2323.

    Article  CAS  PubMed  Google Scholar 

  110. Suranyi-Cadotte, B. E., Wood, P. L., Nair, N. P. V., and Schwartz, G., Normalisation of platelet3H-imipramine binding in depressed patients during remission. Eur. J. Pharmac.85 (1982) 357–358.

    Article  CAS  Google Scholar 

  111. Swade, C., and Coppen, A., Seasonal variations in biochemical factors related to depressive illness. J. affect. Dis.2 (1980) 249–255.

    Article  CAS  PubMed  Google Scholar 

  112. Tam, W. Y. K., Chan Mo-Yin, and Lee, P. H. K., The menstrual cycle and platelet 5-HT uptake. Psychosom. Med.47 (1985) 352–362.

    Article  CAS  PubMed  Google Scholar 

  113. Tang, S. W., and Morris, J. M., Variation in human platelet3H-imipramine binding. Psychiat. Res.16 (1985) 141–146.

    Article  CAS  Google Scholar 

  114. Tanimoto, K., Maeda, K., and Terada, T., Alteration of platelet [3H] imipramine binding in mildly depressed patients correlates with disease severity. Biol. Psychiat.20 (1985) 329–352.

    Article  Google Scholar 

  115. Tuomisto, J., and Tukiainen, E., Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature262 (1976) 596–598.

    Article  CAS  PubMed  Google Scholar 

  116. Uhde, T. W., Berrettini, W. H., Roy-Byrne, P. P., Ballenger, J. P., and Post, R. M., Platelet [3H] imipramine binding in patients with panic disorder. Biol. Psychiat.22 (1987) 52–58.

    Article  CAS  PubMed  Google Scholar 

  117. Wägner, A., Aberg-Wistedt, A., Asberg, M., Ekqvist, B., Märtensson, B., and Montero, D., Lower3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls. Psychiat. Res.16 (1985) 131–139.

    Article  Google Scholar 

  118. Weizman, R., Carmi, M., Tyano, S., Apter, A., and Rehavi, M., High affinity [3H] imipramine binding and serotonin uptake by platelets of adolescent females suffering from anorexia nervosa. Life Sci.38 (1986) 1235–1242.

    Article  CAS  PubMed  Google Scholar 

  119. Whitaker, P. M., Warsh, J. J., Stancer, H. C., Persad, E., and Vint, C. K., Seasonal variation in platelet3H-imipramine binding: Comparable values in control and depressed populations. Psychiat. Res.11 (1984) 127–141.

    Article  CAS  Google Scholar 

  120. Winblad, B., Gottfries, C. G., Oreland, L., and Wiberg, A., Monoamine oxidase in platelets and brain of non-psychiatric and non-neurological geriatric patients. Med. Biol.57 (1981) 129–132.

    Google Scholar 

  121. Wirz-Justice, A., and Chappuis-Arndt, E., Sex specific differences in chlorimipramine inhibition of serotonin uptake in human platelets. Eur. J. Pharmac.40 (1976) 21–25.

    Article  CAS  Google Scholar 

  122. Wirz-Justice, A., and Pühringer, W., Chronic treatment with clomipramine or maprotiline depletes platelet serotonin and modifies its diurnal rhythm. Prog. Neuropsychopharmac.2 (1978) 217–224.

    Article  CAS  Google Scholar 

  123. Wirz-Justice, A., and Pühringer, W., Increased platelet serotonin in bipolar depression and hypomania. J. neural Transm.42 (1978) 55–62.

    Article  CAS  PubMed  Google Scholar 

  124. Wirz-Justice, A., and Pühringer, W., Seasonal incidence of an altered diurnal rhythm of platelet serotonin in unipolar depression. J. neural Transm.42 (1978) 45–53.

    Article  CAS  PubMed  Google Scholar 

  125. Wirz-Justice, A., and Richter, R., Seasonality in biochemical determinations: A source of variance and a clue to the temporal incidence of affective illness. Psychiat. Res.1 (1979) 53–60.

    Article  CAS  Google Scholar 

  126. Wirz-Justice, A., Lichtsteiner, M., and Feer, M., Diurnal and seasonal variations in human platelet serotonin. J. neural Transm.41 (1977) 7–15.

    Article  CAS  PubMed  Google Scholar 

  127. Wirz-Justice, A., Pühringer, W., Hole, G., and Menzi, R., Monoamine oxidase and free tryptophan in human plasma: Normal variations and their implications for biochemical research in affective disorders. Pharmakopsychiat. Neuro-Psychopharmak.8 (1975) 309–317.

    Article  Google Scholar 

  128. Wood, K., and Coppen, A., Prophylactic lithium treatment of patients with affective disorders is associated with decreased platelet [3H] dihydroergocryptine binding. J. affect. Dis.5 (1983) 253–258.

    Article  CAS  PubMed  Google Scholar 

  129. Wood, K., Swade, C., Abou-Saleh, M. T., and Coppen, A., Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients. J. affect. Dis.8 (1985) 69–72.

    Article  CAS  PubMed  Google Scholar 

  130. Wood, P. L., Suranyi-Cadotte, B., Nair, N. P. V., LaFaille, F., and Schwartz, G., Lack of association between [3H] imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Neuropharmacology22 (1983) 1211–1214.

    Article  CAS  PubMed  Google Scholar 

  131. Wood, P. L., Suranyi-Cadotte, B., Schwartz, G., and Nair, N. P., Platelet3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis. Biol. Psychiat.18 (1983) 715–719.

    CAS  PubMed  Google Scholar 

  132. Zubin, J., Psychobiological markers for schizophrenia: State of the art and future perspectives. Psychopharmac. Bull.21 (1985) 490–496.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatric University Clinic, CH-4025, Basel, Switzerland

    A. Wirz-Justice

Authors
  1. A. Wirz-Justice
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wirz-Justice, A. Platelet research in psychiatry. Experientia 44, 145–152 (1988). https://doi.org/10.1007/BF01952199

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01952199

Key words

Search

Navigation